For instance, Bcl-2 family proteins are known to modulate gemcitabine sensitivity in pancreatic cancer cells56, and TIMP1 has been shown to counteract gemcitabine resistance by promoting apoptosis57. This evidence concerns the gene BCL2 and familial pancreatic carcinoma.